Investigating neurological disorders in people living with HIV
Neurological Disorders in HIV-1 Infection
This study is looking at how a substance related to sugar breakdown might affect brain health in middle-aged people with HIV, using mice to see if lowering this substance can help improve their symptoms.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Nebraska Medical Center NIH-funded |
| Lab location | 1 site (Omaha, United States) |
| Project ID | NIH-11008730 on NIH RePORTER |
What this research studies
This research focuses on understanding the neurological disorders associated with HIV infection, particularly in middle-aged individuals. It aims to explore the role of a glycolytic byproduct called methylglyoxal in triggering these disorders by examining its effects on different brain cell types. The study will utilize a mouse model to investigate the relationship between methylglyoxal levels, inflammation, and neurological function, as well as test new treatments using cyclic peptides to reduce methylglyoxal and potentially alleviate symptoms.
Who could benefit from this research
Good fit: Ideal candidates for this research are middle-aged individuals living with HIV who are experiencing neurological symptoms.
Not a fit: Patients who are not living with HIV or who do not exhibit neurological symptoms may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for neurological disorders in people living with HIV.
How similar studies have performed: While the specific approach of targeting methylglyoxal in this context is novel, related research has shown promise in understanding and treating neurological disorders in HIV-infected populations.
Where this research is happening
Omaha, United States
- University of Nebraska Medical Center — Omaha, United States (Active)
Researchers
- Principal investigator: Bidasee, Keshore R — University of Nebraska Medical Center
- Study coordinator: Bidasee, Keshore R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.